614 related articles for article (PubMed ID: 31490536)
1. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
[TBL] [Abstract][Full Text] [Related]
2. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
[TBL] [Abstract][Full Text] [Related]
5. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
[TBL] [Abstract][Full Text] [Related]
6. Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
Easton JD; Denison H; Evans SR; Knutsson M; Amarenco P; Albers GW; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC;
Int J Stroke; 2019 Dec; 14(9):908-914. PubMed ID: 31092152
[TBL] [Abstract][Full Text] [Related]
7. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
[TBL] [Abstract][Full Text] [Related]
9. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
[TBL] [Abstract][Full Text] [Related]
10. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC
Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events: A Secondary Analysis of the COMPASS Trial.
Gaba P; Bhatt DL; Dagenais GR; Bosch J; Maggioni AP; Widimsky P; Leong D; Fox KAA; Yusuf S; Eikelboom JW;
JAMA Netw Open; 2022 Nov; 5(11):e2243201. PubMed ID: 36409491
[TBL] [Abstract][Full Text] [Related]
12. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.
Johnston SC; Easton JD; Farrant M; Barsan W; Battenhouse H; Conwit R; Dillon C; Elm J; Lindblad A; Morgenstern L; Poisson SN; Palesch Y
Int J Stroke; 2013 Aug; 8(6):479-83. PubMed ID: 23879752
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial.
de Havenon A; Johnston SC; Easton JD; Kim AS; Sheth KN; Lansberg M; Tirschwell D; Mistry E; Yaghi S
JAMA Netw Open; 2021 Jun; 4(6):e2112551. PubMed ID: 34086033
[TBL] [Abstract][Full Text] [Related]
14. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
15. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.
Wang Y; Wang Y; Zhao X; Liu L; Wang D; Wang C; Wang C; Li H; Meng X; Cui L; Jia J; Dong Q; Xu A; Zeng J; Li Y; Wang Z; Xia H; Johnston SC;
N Engl J Med; 2013 Jul; 369(1):11-9. PubMed ID: 23803136
[TBL] [Abstract][Full Text] [Related]
18. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
[TBL] [Abstract][Full Text] [Related]
19. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.
Gao Y; Chen W; Pan Y; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Jiang L; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y;
N Engl J Med; 2023 Dec; 389(26):2413-2424. PubMed ID: 38157499
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial.
Chen HS; Cui Y; Wang XH; Ma YT; Han J; Duan YJ; Lu J; Shen LY; Liang Y; Wang WZ; Wang H; Zhao Y; Zhang JT; Song YL; He XM; Li RH; Tao DB; Li J; Huang SM; Wang N; Hong M; Meng C; Zhang W; Wang DL; Nguyen TN;
JAMA Neurol; 2024 May; 81(5):450-460. PubMed ID: 38466274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
